Structure Therapeutics, Inc. (GPCR)
23.89
-1.65
(-6.46%)
USD |
NASDAQ |
Oct 12, 16:00
24.36
+0.47
(+1.97%)
After-Hours: 19:11
Structure Therapeutics Net Income (TTM) : -215.18M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -215.18M |
| March 31, 2026 | -170.73M |
| December 31, 2025 | -141.43M |
| September 30, 2025 | -210.93M |
| June 30, 2025 | -179.38M |
| March 31, 2025 | -143.51M |
| December 31, 2024 | -122.60M |
| September 30, 2024 | -110.93M |
| Date | Value |
|---|---|
| June 30, 2024 | -100.53M |
| March 31, 2024 | -97.56M |
| December 31, 2023 | -89.51M |
| September 30, 2023 | -76.69M |
| June 30, 2023 | -66.70M |
| March 31, 2023 | -56.77M |
| December 31, 2022 | -54.18M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Eli Lilly & Co. | 26.71B |
| Novo Nordisk A/S | 18.19B |
| Pfizer Inc. | 4.373B |
| Viking Therapeutics, Inc. | -534.80M |
| Liquidia Corp. | 138.61M |